Skip to main content
Erschienen in: Acta Diabetologica 6/2015

01.12.2015 | Original Article

Early second-trimester plasma protein profiling using multiplexed isobaric tandem mass tag (TMT) labeling predicts gestational diabetes mellitus

verfasst von: Chun Zhao, Fuqiang Wang, Ping Wang, Hongjuan Ding, Xiaoyan Huang, Zhonghua Shi

Erschienen in: Acta Diabetologica | Ausgabe 6/2015

Einloggen, um Zugang zu erhalten

Abstract

Aims

Gestational diabetes mellitus (GDM) is associated with an increased risk of serious complications for mother and child during pregnancy. The main option for diagnosis of GDM is 75 g oral glucose tolerance test (OGTT) at 24–28 gestation weeks, when harms to both mother and child have already potentially occurred. The aim of this study was to investigate new biomarkers for earlier detection and assessment of GDM at early second trimester (16–18 gestation weeks).

Methods

We systematically used multiplexed isobaric tandem mass tag labeling combined with liquid chromatography mass spectrometry (LC-MS/MS) to screen differentially expressed proteins in plasma collected at 16–18 gestational weeks between pregnant women with and without GDM outcome.

Results

A total of 828 proteins were identified, of which 36 proteins implicated in immune response, inflammation, transport, platelet aggregation, catalyze and defense response were identified as differentially regulated proteins in GDM. To assess the validity of the results, four selected proteins including C-reactive protein, sex hormone-binding globulin, Ficolin 3 and pregnancy-specific beta-1-glycoprotein 4 were selected for subsequent Western blot analysis.

Conclusions

This is the first comprehensive study that integrates multiple state-of-the-art proteomic technologies to discover the earlier potential plasma biomarkers for GDM.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
2.
Zurück zum Zitat Ruchat SM, Mottola MF (2013) The important role of physical activity in the prevention and management of gestational diabetes mellitus. Diabetes Metab Res Rev 29(5):334–346CrossRefPubMed Ruchat SM, Mottola MF (2013) The important role of physical activity in the prevention and management of gestational diabetes mellitus. Diabetes Metab Res Rev 29(5):334–346CrossRefPubMed
3.
Zurück zum Zitat Wahabi HA, Alzeidan RA, Esmaeil SA (2012) Pre-pregnancy care for women with pre-gestational diabetes mellitus: a systematic review and meta-analysis. BMC Public Health 12:792PubMedCentralCrossRefPubMed Wahabi HA, Alzeidan RA, Esmaeil SA (2012) Pre-pregnancy care for women with pre-gestational diabetes mellitus: a systematic review and meta-analysis. BMC Public Health 12:792PubMedCentralCrossRefPubMed
4.
Zurück zum Zitat Buchanan TA, Xiang AH, Page KA (2012) Gestational diabetes mellitus: risks and management during and after pregnancy. Nat Rev Endocrinol 8(11):639–649PubMedCentralCrossRefPubMed Buchanan TA, Xiang AH, Page KA (2012) Gestational diabetes mellitus: risks and management during and after pregnancy. Nat Rev Endocrinol 8(11):639–649PubMedCentralCrossRefPubMed
5.
Zurück zum Zitat Metzger BE, Gabbe SG, Persson B, Buchanan TA, Catalano PM, Damm P, Dyer AR, Hod M, Kitzmiller JL, Lowe LP, McIntyre HD, Oats JJ, Omori Y (2012) The diagnosis of gestational diabetes mellitus: new paradigms or status quo? J Matern Fetal Neonatal Med 25(12):2564–2569CrossRefPubMed Metzger BE, Gabbe SG, Persson B, Buchanan TA, Catalano PM, Damm P, Dyer AR, Hod M, Kitzmiller JL, Lowe LP, McIntyre HD, Oats JJ, Omori Y (2012) The diagnosis of gestational diabetes mellitus: new paradigms or status quo? J Matern Fetal Neonatal Med 25(12):2564–2569CrossRefPubMed
6.
Zurück zum Zitat Oostdam N, van Poppel MN, Wouters MG, van Mechelen W (2011) Interventions for preventing gestational diabetes mellitus: a systematic review and meta-analysis. J Womens Health (Larchmt) 20(10):1551–1563CrossRef Oostdam N, van Poppel MN, Wouters MG, van Mechelen W (2011) Interventions for preventing gestational diabetes mellitus: a systematic review and meta-analysis. J Womens Health (Larchmt) 20(10):1551–1563CrossRef
7.
8.
Zurück zum Zitat Elvidge T, Matthews IP, Gregory C, Hoogendoorn B (2013) Feasibility of using biomarkers in blood serum as markers of effect following exposure of the lungs to particulate matter air pollution. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 31(1):1–44CrossRefPubMed Elvidge T, Matthews IP, Gregory C, Hoogendoorn B (2013) Feasibility of using biomarkers in blood serum as markers of effect following exposure of the lungs to particulate matter air pollution. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 31(1):1–44CrossRefPubMed
9.
Zurück zum Zitat Liu B, Xu Y, Voss C, Qiu FH, Zhao MZ, Liu YD, Nie J, Wang ZL (2012) Altered protein expression in gestational diabetes mellitus placentas provides insight into insulin resistance and coagulation/fibrinolysis pathways. PLoS ONE 7(9):e44701PubMedCentralCrossRefPubMed Liu B, Xu Y, Voss C, Qiu FH, Zhao MZ, Liu YD, Nie J, Wang ZL (2012) Altered protein expression in gestational diabetes mellitus placentas provides insight into insulin resistance and coagulation/fibrinolysis pathways. PLoS ONE 7(9):e44701PubMedCentralCrossRefPubMed
10.
Zurück zum Zitat Oliva K, Barker G, Rice GE, Bailey MJ, Lappas M (2013) 2d-DIGE to identify proteins associated with gestational diabetes in omental adipose tissue. J Endocrinol 218(2):165–178CrossRefPubMed Oliva K, Barker G, Rice GE, Bailey MJ, Lappas M (2013) 2d-DIGE to identify proteins associated with gestational diabetes in omental adipose tissue. J Endocrinol 218(2):165–178CrossRefPubMed
11.
Zurück zum Zitat Adkins JN, Varnum SM, Auberry KJ, Moore RJ, Angell NH, Smith RD, Springer DL, Pounds JG (2002) Toward a human blood serum proteome analysis by multidimensional separation coupled with mass spectrometry. Mol Cell Proteomics 1(12):947–955CrossRefPubMed Adkins JN, Varnum SM, Auberry KJ, Moore RJ, Angell NH, Smith RD, Springer DL, Pounds JG (2002) Toward a human blood serum proteome analysis by multidimensional separation coupled with mass spectrometry. Mol Cell Proteomics 1(12):947–955CrossRefPubMed
12.
Zurück zum Zitat Antoniewicz MR (2013) Tandem mass spectrometry for measuring stable-isotope labeling. Curr Opin Biotechnol 24(1):48–53CrossRefPubMed Antoniewicz MR (2013) Tandem mass spectrometry for measuring stable-isotope labeling. Curr Opin Biotechnol 24(1):48–53CrossRefPubMed
13.
Zurück zum Zitat Ong SE, Blagoev B, Kratchmarova I, Kristensen DB, Steen H, Pandey A, Mann M (2002) Stable isotope labeling by amino acids in cell culture, silac, as a simple and accurate approach to expression proteomics. Mol Cell Proteomics 1(5):376–386CrossRefPubMed Ong SE, Blagoev B, Kratchmarova I, Kristensen DB, Steen H, Pandey A, Mann M (2002) Stable isotope labeling by amino acids in cell culture, silac, as a simple and accurate approach to expression proteomics. Mol Cell Proteomics 1(5):376–386CrossRefPubMed
14.
Zurück zum Zitat Wiese S, Reidegeld KA, Meyer HE, Warscheid B (2007) Protein labeling by itraq: a new tool for quantitative mass spectrometry in proteome research. Proteomics 7(3):340–350CrossRefPubMed Wiese S, Reidegeld KA, Meyer HE, Warscheid B (2007) Protein labeling by itraq: a new tool for quantitative mass spectrometry in proteome research. Proteomics 7(3):340–350CrossRefPubMed
15.
Zurück zum Zitat Sui P, Watanabe H, Ossipov MH, Porreca F, Bakalkin G, Bergquist J, Artemenko K (2013) Dimethyl-labeling-based protein quantification and pathway search: a novel method of spinal cord analysis applicable for neurological studies. J Proteome Res 12(5):2245–2252CrossRefPubMed Sui P, Watanabe H, Ossipov MH, Porreca F, Bakalkin G, Bergquist J, Artemenko K (2013) Dimethyl-labeling-based protein quantification and pathway search: a novel method of spinal cord analysis applicable for neurological studies. J Proteome Res 12(5):2245–2252CrossRefPubMed
16.
Zurück zum Zitat Rayavarapu S, Coley W, Cakir E, Jahnke V, Takeda S, Aoki Y, Grodish-Dressman H, Jaiswal JK, Hoffman EP, Brown KJ, Hathout Y, Nagaraju K (2013) Identification of disease specific pathways using in vivo silac proteomics in dystrophin deficient mdx mouse. Mol Cell Proteomics 12(5):1061–1073PubMedCentralCrossRefPubMed Rayavarapu S, Coley W, Cakir E, Jahnke V, Takeda S, Aoki Y, Grodish-Dressman H, Jaiswal JK, Hoffman EP, Brown KJ, Hathout Y, Nagaraju K (2013) Identification of disease specific pathways using in vivo silac proteomics in dystrophin deficient mdx mouse. Mol Cell Proteomics 12(5):1061–1073PubMedCentralCrossRefPubMed
17.
Zurück zum Zitat Dayon L, Sanchez JC (2012) Relative protein quantification by ms/ms using the tandem mass tag technology. Methods Mol Biol 893:115–127CrossRefPubMed Dayon L, Sanchez JC (2012) Relative protein quantification by ms/ms using the tandem mass tag technology. Methods Mol Biol 893:115–127CrossRefPubMed
18.
Zurück zum Zitat Tsuchida S, Satoh M, Kawashima Y, Sogawa K, Kado S, Sawai S, Nishimura M, Ogita M, Takeuchi Y, Kobyashi H, Aoki A, Kodera Y, Matsushita K, Izumi Y, Nomura F (2013) Application of quantitative proteomic analysis using tandem mass tags for discovery and identification of novel biomarkers in periodontal disease. Proteomics 13(15):2339–2350CrossRefPubMed Tsuchida S, Satoh M, Kawashima Y, Sogawa K, Kado S, Sawai S, Nishimura M, Ogita M, Takeuchi Y, Kobyashi H, Aoki A, Kodera Y, Matsushita K, Izumi Y, Nomura F (2013) Application of quantitative proteomic analysis using tandem mass tags for discovery and identification of novel biomarkers in periodontal disease. Proteomics 13(15):2339–2350CrossRefPubMed
19.
Zurück zum Zitat Maes E, Valkenborg D, Mertens I, Broeckx V, Baggerman G, Sagaert X, Landuyt B, Prenen H, Schoofs L (2013) Proteomic analysis of formalin-fixed paraffin-embedded colorectal cancer tissue using tandem mass tag protein labeling. Mol BioSyst 9(11):2686–2695CrossRefPubMed Maes E, Valkenborg D, Mertens I, Broeckx V, Baggerman G, Sagaert X, Landuyt B, Prenen H, Schoofs L (2013) Proteomic analysis of formalin-fixed paraffin-embedded colorectal cancer tissue using tandem mass tag protein labeling. Mol BioSyst 9(11):2686–2695CrossRefPubMed
20.
Zurück zum Zitat Ruckhaberle E, Karn T, Hanker L, Schwarz J, Schulz-Knappe P, Kuhn K, Bohm G, Selzer S, Erhard N, Engels K, Holtrich U, Kaufmann M, Rody A (2010) Breast cancer proteomics—differences in protein expression between estrogen receptor-positive and -negative tumors identified by tandem mass tag technology. Breast Care (Basel) 5(1):7–10CrossRef Ruckhaberle E, Karn T, Hanker L, Schwarz J, Schulz-Knappe P, Kuhn K, Bohm G, Selzer S, Erhard N, Engels K, Holtrich U, Kaufmann M, Rody A (2010) Breast cancer proteomics—differences in protein expression between estrogen receptor-positive and -negative tumors identified by tandem mass tag technology. Breast Care (Basel) 5(1):7–10CrossRef
21.
Zurück zum Zitat Georgiou HM, Lappas M, Georgiou GM, Marita A, Bryant VJ, Hiscock R, Permezel M, Khalil Z, Rice GE (2008) Screening for biomarkers predictive of gestational diabetes mellitus. Acta Diabetol 45(3):157–165CrossRefPubMed Georgiou HM, Lappas M, Georgiou GM, Marita A, Bryant VJ, Hiscock R, Permezel M, Khalil Z, Rice GE (2008) Screening for biomarkers predictive of gestational diabetes mellitus. Acta Diabetol 45(3):157–165CrossRefPubMed
22.
Zurück zum Zitat Farrah T, Deutsch EW, Omenn GS, Campbell DS, Sun Z, Bletz JA, Mallick P, Katz JE, Malmstrom J, Ossola R, Watts JD, Lin B, Zhang H, Moritz RL, Aebersold R (2011) A high-confidence human plasma proteome reference set with estimated concentrations in peptideatlas. Mol Cell Proteomics 10(9):M110–M006353PubMedCentralCrossRefPubMed Farrah T, Deutsch EW, Omenn GS, Campbell DS, Sun Z, Bletz JA, Mallick P, Katz JE, Malmstrom J, Ossola R, Watts JD, Lin B, Zhang H, Moritz RL, Aebersold R (2011) A high-confidence human plasma proteome reference set with estimated concentrations in peptideatlas. Mol Cell Proteomics 10(9):M110–M006353PubMedCentralCrossRefPubMed
23.
Zurück zum Zitat Maged AM, Moety GA, Mostafa WA, Hamed DA (2013) Comparative study between different biomarkers for early prediction of gestational diabetes mellitus. J Matern Fetal Neonatal Med 27(11):1108–1112CrossRefPubMed Maged AM, Moety GA, Mostafa WA, Hamed DA (2013) Comparative study between different biomarkers for early prediction of gestational diabetes mellitus. J Matern Fetal Neonatal Med 27(11):1108–1112CrossRefPubMed
24.
Zurück zum Zitat D’Anna R, Baviera G, De Vivo A, Facciola G, Di Benedetto A, Corrado F (2006) C-reactive protein as an early predictor of gestational diabetes mellitus. J Reprod Med 51(1):55–58PubMed D’Anna R, Baviera G, De Vivo A, Facciola G, Di Benedetto A, Corrado F (2006) C-reactive protein as an early predictor of gestational diabetes mellitus. J Reprod Med 51(1):55–58PubMed
25.
Zurück zum Zitat Caglar GS, Ozdemir ED, Cengiz SD, Demirtas S (2012) Sex-hormone-binding globulin early in pregnancy for the prediction of severe gestational diabetes mellitus and related complications. J Obstet Gynaecol Res 38(11):1286–1293CrossRefPubMed Caglar GS, Ozdemir ED, Cengiz SD, Demirtas S (2012) Sex-hormone-binding globulin early in pregnancy for the prediction of severe gestational diabetes mellitus and related complications. J Obstet Gynaecol Res 38(11):1286–1293CrossRefPubMed
26.
Zurück zum Zitat Li RX, Chen HB, Tu K, Zhao SL, Zhou H, Li SJ, Dai J, Li QR, Nie S, Li YX, Jia WP, Zeng R, Wu JR (2008) Localized-statistical quantification of human serum proteome associated with type 2 diabetes. PLoS ONE 3(9):e3224PubMedCentralCrossRefPubMed Li RX, Chen HB, Tu K, Zhao SL, Zhou H, Li SJ, Dai J, Li QR, Nie S, Li YX, Jia WP, Zeng R, Wu JR (2008) Localized-statistical quantification of human serum proteome associated with type 2 diabetes. PLoS ONE 3(9):e3224PubMedCentralCrossRefPubMed
27.
Zurück zum Zitat Fuchtenbusch M, Bonifacio E, Lampasona V, Knopff A, Ziegler AG (2004) Immune responses to glutamic acid decarboxylase and insulin in patients with gestational diabetes. Clin Exp Immunol 135(2):318–321PubMedCentralCrossRefPubMed Fuchtenbusch M, Bonifacio E, Lampasona V, Knopff A, Ziegler AG (2004) Immune responses to glutamic acid decarboxylase and insulin in patients with gestational diabetes. Clin Exp Immunol 135(2):318–321PubMedCentralCrossRefPubMed
28.
Zurück zum Zitat Han S, Middleton P, Crowther CA (2012) Exercise for pregnant women for preventing gestational diabetes mellitus. Cochrane Database Syst Rev 7:CD009021PubMed Han S, Middleton P, Crowther CA (2012) Exercise for pregnant women for preventing gestational diabetes mellitus. Cochrane Database Syst Rev 7:CD009021PubMed
29.
Zurück zum Zitat Kim SY, England JL, Sharma JA, Njoroge T (2011) Gestational diabetes mellitus and risk of childhood overweight and obesity in offspring: a systematic review. Exp Diabetes Res 2011:541308PubMedCentralCrossRefPubMed Kim SY, England JL, Sharma JA, Njoroge T (2011) Gestational diabetes mellitus and risk of childhood overweight and obesity in offspring: a systematic review. Exp Diabetes Res 2011:541308PubMedCentralCrossRefPubMed
30.
Zurück zum Zitat Aguiar FJ, Ferreira-Junior M, Sales MM, Cruz-Neto LM, Fonseca LA, Sumita NM, Duarte NJ, Lichtenstein A, Duarte AJ (2013) C-reactive protein: clinical applications and proposals for a rational use. Rev Assoc Med Bras 59(1):85–92CrossRefPubMed Aguiar FJ, Ferreira-Junior M, Sales MM, Cruz-Neto LM, Fonseca LA, Sumita NM, Duarte NJ, Lichtenstein A, Duarte AJ (2013) C-reactive protein: clinical applications and proposals for a rational use. Rev Assoc Med Bras 59(1):85–92CrossRefPubMed
31.
Zurück zum Zitat Gabay C, Kushner I (1999) Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 340(6):448–454CrossRefPubMed Gabay C, Kushner I (1999) Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 340(6):448–454CrossRefPubMed
32.
Zurück zum Zitat Szalai AJ, Agrawal A, Greenhough TJ, Volanakis JE (1999) C-reactive protein: structural biology and host defense function. Clin Chem Lab Med 37(3):265–270CrossRefPubMed Szalai AJ, Agrawal A, Greenhough TJ, Volanakis JE (1999) C-reactive protein: structural biology and host defense function. Clin Chem Lab Med 37(3):265–270CrossRefPubMed
33.
Zurück zum Zitat Le TN, Nestler JE, Strauss JF 3rd, Wickham EP 3rd (2012) Sex hormone-binding globulin and type 2 diabetes mellitus. Trends Endocrinol Metab 23(1):32–40PubMedCentralCrossRefPubMed Le TN, Nestler JE, Strauss JF 3rd, Wickham EP 3rd (2012) Sex hormone-binding globulin and type 2 diabetes mellitus. Trends Endocrinol Metab 23(1):32–40PubMedCentralCrossRefPubMed
34.
Zurück zum Zitat Chen C, Smothers J, Lange A, Nestler JE, Strauss Iii JF, Wickham Iii EP (2010) Sex hormone-binding globulin genetic variation: associations with type 2 diabetes mellitus and polycystic ovary syndrome. Minerva Endocrinol 35(4):271–280PubMedCentralPubMed Chen C, Smothers J, Lange A, Nestler JE, Strauss Iii JF, Wickham Iii EP (2010) Sex hormone-binding globulin genetic variation: associations with type 2 diabetes mellitus and polycystic ovary syndrome. Minerva Endocrinol 35(4):271–280PubMedCentralPubMed
35.
Zurück zum Zitat Kopp HP, Festa A, Krugluger W, Schernthaner G (2001) Low levels of sex-hormone-binding globulin predict insulin requirement in patients with gestation diabetes mellitus. Exp Clin Endocrinol Diabetes 109(7):365–369CrossRefPubMed Kopp HP, Festa A, Krugluger W, Schernthaner G (2001) Low levels of sex-hormone-binding globulin predict insulin requirement in patients with gestation diabetes mellitus. Exp Clin Endocrinol Diabetes 109(7):365–369CrossRefPubMed
36.
Zurück zum Zitat Martinez FF, Cervi L, Knubel CP, Panzetta-Dutari GM, Motran CC (2013) The role of pregnancy-specific glycoprotein 1a (psg1a) in regulating the innate and adaptive immune response. Am J Reprod Immunol 69(4):383–394CrossRefPubMed Martinez FF, Cervi L, Knubel CP, Panzetta-Dutari GM, Motran CC (2013) The role of pregnancy-specific glycoprotein 1a (psg1a) in regulating the innate and adaptive immune response. Am J Reprod Immunol 69(4):383–394CrossRefPubMed
37.
Zurück zum Zitat Grudzinskas JG, Gordon YB, Menabawey M, Lee JN, Wadsworth J, Chard T (1983) Identification of high-risk pregnancy by the routine measurement of pregnancy-specific beta 1-glycoprotein. Am J Obstet Gynecol 147(1):10–12PubMed Grudzinskas JG, Gordon YB, Menabawey M, Lee JN, Wadsworth J, Chard T (1983) Identification of high-risk pregnancy by the routine measurement of pregnancy-specific beta 1-glycoprotein. Am J Obstet Gynecol 147(1):10–12PubMed
38.
Zurück zum Zitat Zhang XL, Ali MA (2008) Ficolins: structure, function and associated diseases. Adv Exp Med Biol 632:105–115PubMed Zhang XL, Ali MA (2008) Ficolins: structure, function and associated diseases. Adv Exp Med Biol 632:105–115PubMed
39.
Zurück zum Zitat Szala A, Sawicki S, Swierzko AS, Szemraj J, Sniadecki M, Michalski M, Kaluzynski A, Lukasiewicz J, Maciejewska A, Wydra D, Kilpatrick DC, Matsushita M, Cedzynski M (2013) Ficolin-2 and ficolin-3 in women with malignant and benign ovarian tumours. Cancer Immunol Immunother 62(8):1411–1419PubMedCentralCrossRefPubMed Szala A, Sawicki S, Swierzko AS, Szemraj J, Sniadecki M, Michalski M, Kaluzynski A, Lukasiewicz J, Maciejewska A, Wydra D, Kilpatrick DC, Matsushita M, Cedzynski M (2013) Ficolin-2 and ficolin-3 in women with malignant and benign ovarian tumours. Cancer Immunol Immunother 62(8):1411–1419PubMedCentralCrossRefPubMed
40.
Zurück zum Zitat Halmos A, Rigo J Jr, Szijarto J, Fust G, Prohaszka Z, Molvarec A (2012) Circulating ficolin-2 and ficolin-3 in normal pregnancy and pre-eclampsia. Clin Exp Immunol 169(1):49–56PubMedCentralCrossRefPubMed Halmos A, Rigo J Jr, Szijarto J, Fust G, Prohaszka Z, Molvarec A (2012) Circulating ficolin-2 and ficolin-3 in normal pregnancy and pre-eclampsia. Clin Exp Immunol 169(1):49–56PubMedCentralCrossRefPubMed
41.
Zurück zum Zitat Chen H, Lu J, Chen X, Yu H, Zhang L, Bao Y, Lu F, Tang J, Gu C, Jia W (2012) Low serum levels of the innate immune component ficolin-3 is associated with insulin resistance and predicts the development of type 2 diabetes. J Mol Cell Biol 4(4):256–257CrossRefPubMed Chen H, Lu J, Chen X, Yu H, Zhang L, Bao Y, Lu F, Tang J, Gu C, Jia W (2012) Low serum levels of the innate immune component ficolin-3 is associated with insulin resistance and predicts the development of type 2 diabetes. J Mol Cell Biol 4(4):256–257CrossRefPubMed
42.
Zurück zum Zitat Rho JH, Roehrl MH, Wang JY (2009) Tissue proteomics reveals differential and compartment-specific expression of the homologs transgelin and transgelin-2 in lung adenocarcinoma and its stroma. J Proteome Res 8(12):5610–5618PubMedCentralCrossRefPubMed Rho JH, Roehrl MH, Wang JY (2009) Tissue proteomics reveals differential and compartment-specific expression of the homologs transgelin and transgelin-2 in lung adenocarcinoma and its stroma. J Proteome Res 8(12):5610–5618PubMedCentralCrossRefPubMed
43.
Zurück zum Zitat Zhang Y, Ye Y, Shen D, Jiang K, Zhang H, Sun W, Zhang J, Xu F, Cui Z, Wang S (2010) Identification of transgelin-2 as a biomarker of colorectal cancer by laser capture microdissection and quantitative proteome analysis. Cancer Sci 101(2):523–529CrossRefPubMed Zhang Y, Ye Y, Shen D, Jiang K, Zhang H, Sun W, Zhang J, Xu F, Cui Z, Wang S (2010) Identification of transgelin-2 as a biomarker of colorectal cancer by laser capture microdissection and quantitative proteome analysis. Cancer Sci 101(2):523–529CrossRefPubMed
44.
Zurück zum Zitat De Seymour JV, Conlon CA, Sulek K, Villas Bôas SG, McCowan LM, Kenny LC, Baker PN (2014) Early pregnancy metabolite profiling discovers a potential biomarker for the subsequent development of gestational diabetes mellitus. Acta Diabetol 51(5):887–890CrossRefPubMed De Seymour JV, Conlon CA, Sulek K, Villas Bôas SG, McCowan LM, Kenny LC, Baker PN (2014) Early pregnancy metabolite profiling discovers a potential biomarker for the subsequent development of gestational diabetes mellitus. Acta Diabetol 51(5):887–890CrossRefPubMed
Metadaten
Titel
Early second-trimester plasma protein profiling using multiplexed isobaric tandem mass tag (TMT) labeling predicts gestational diabetes mellitus
verfasst von
Chun Zhao
Fuqiang Wang
Ping Wang
Hongjuan Ding
Xiaoyan Huang
Zhonghua Shi
Publikationsdatum
01.12.2015
Verlag
Springer Milan
Erschienen in
Acta Diabetologica / Ausgabe 6/2015
Print ISSN: 0940-5429
Elektronische ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-015-0796-y

Weitere Artikel der Ausgabe 6/2015

Acta Diabetologica 6/2015 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.